Amsbio has introduced an expanded range of Skeletal Muscle Differentiation Kits designed to reproducibly convert pluripotent or embryonic stem cells into myoblasts with high regenerative potential.
Using a simple 3-step process of media changes and cell passaging – these advanced kits can typically achieve 70% MF20-positive myotubes. The highly efficient protocol employed by the kit does not require genetic intervention or cell sorting, thereby saving you valuable time.
Not only do Amsbio Skeletal Muscle Differentiation kits work with all pluripotent stem…
We are pleased to announce the shortlist for the One Nucleus Awards 2026.
The One Nucleus Award categories are structured to reflect that breadth of R&D, investment, service provision and enabling support across the stakeholders.
Best Therapeutic R&D Programme of the Year:⭐Resolution Therapeutics⭐Serenatis Bio⭐Trimtech Therapeutics Ltd
Best Use of Emerging Technology of the Year:⭐Ignota Labs⭐Constructive Bio⭐Nuclera Ltd
Best Industry and Not for Profit Collaboration of the Year:⭐ LifeArc⭐ Cellestial Health Ltd⭐Aspire Biosciences
Most Innovative Professional Services Company of the…
Sandwich, UK - 9 February 2026: To mark National Apprenticeship Week (9 - 15 February), Kent’s science and technology hub Discovery Park is calling for more young people to consider higher apprenticeships as a route into rewarding careers in STEM (Science, Technology, Engineering, and Maths).
Last year, 3,850 young people in Kent started a higher apprenticeship programme, a 22% increase on the previous year. Higher apprenticeships include degree apprenticeships - where students gain a full undergraduate or master’s degree without student fees - and also Higher National Diplomas and…
Royston, 3 February 2026.Pharmagene Discovery Services Ltd. (‘Pharmagene’) is pleased to announce its launch and that its co-founding management team has completed the asset purchase of an established human tissue laboratory business based near Cambridge, UK. The business is specialised in the performance of laboratory-based research services using consented human tissue across both preclinical and clinical settings. Originally founded back in 1996 and returning to its original trading name, the business has a unique heritage of conducting hundreds of human tissue studies for clients around…
Starting something new is hard – particularly within the fast-moving life science sector. Step forward Accelerate@Babraham, the Babraham Research Campus’ bio-incubator, founded out of a desire to support and nurture early-stage ventures; bringing to bear an unrivalled network of experts, mentors and investors and data-driven, comprehensive business analysis and support to equip these young enterprises with the skills, confidence and network connections to enable success.
Now in our eighth year, Accelerate@Babraham companies have raised £72.5m and have a current portfolio value estimated at…
LONDON, UK and COPENHAGEN, Denmark – February 2, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for Kaffe Bueno and is pleased to announce the placement of Thomas Durhuus as Chief Executive Officer (CEO).Kaffe Bueno is a Danish bioscience company and certified B Corp that upcycles coffee by-products into high-performance, active, and functional ingredients. Using green chemistry and biotechnology, the company unlocks the full potential of coffee by-products…
London, 06.01.2026: Bidwells has completed the merger of Creative Places LLP into the firm, strengthening its Science & Technology capability and further enhancing its expertise in R&D and innovation-led real estate.
Creative Places, an award-winning specialist consultancy focused on R&D and innovation spaces, was established with Bidwells in 2009. Following the merger, the Creative Places team will continue and operate as part of Bidwells’ Commercial Department, enhancing the firm’s Agency and Consultancy services for clients operating in the…
Cambridge, UK, 22 January 2026: We are pleased to share that Outsee, A Cambridge-based genomics and drug discovery fledgling company, has closed its £2.5 million seed round and signed what could prove an important strategic deal with o2h discovery, headquartered in Cambridge, UK, and Ahmedabad, India. OutSee is pioneering what it calls a unique AI-based predictive genomics approach to target discovery. It was shortlisted for last September’s Business Weekly Awards. The seed round was led by Ahren Innovation Capital, with Kadmos Capital, Panacea, Empirical Ventures, and 26 independent…
London, UK and Paris, FRANCE – January 27, 2026 – Coulter Partners, the global expert building leadership teams for Health, Science and Technology innovation businesses, successfully led a search assignment for TreeFrog Therapeutics and is pleased to announce the placement of Mark Rothera as Chief Executive Officer (CEO).TreeFrog Therapeutics is a French regenerative medicine biotech focused on providing mass access to cell therapies. By combining biophysics and engineering, they produce high-quality cells at unprecedented scale and cost-effectiveness through internal programs and…
Godmanchester PE29 2XG
Situated on a new industrial park next to A14 with other high tech users including CDT, pharmaceutical companies and healthcare multinationals (Smith and Nephew). Cambridge 15 miles via upgraded A14.
Offered as a single unit of 10,000 sq ft. or as one or two separate units of 5,000 sq ft.
Units can be separated into two separate 5,000 sq ft units.
Dry labs
Wet labs
Fume Hoods
Office areas
Production suites (air conditioned, filtered air with option of low RH (5% RH) rooms)
Upgraded electrical supplies and RO water supplies to lab areas
Currently registered…